AFT Pharmaceuticals reports ongoing sales growth and R&D progress
AFT Pharmaceuticals has achieved sustained growth at the start of the 2027 FY and is on track to reach its $300 million revenue target.
Market Cap $26.72M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
